United States · FDA National Drug Code directory
Meclizine HCL 12.5 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17714-117_5cc9755e-6d41-fa9f-e053-2991aa0afbef
- Product NDC
- 17714-117
- Form
- TABLET
- Composition / generic term
- Meclizine HCL 12.5 mg
- Labeler
- Advance Pharmaceutical Inc.
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start / end (source format)
- 20130701
- Source listing expiry
- 20261231
Source-listed ingredients
- MECLIZINE HYDROCHLORIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (17714-117-01) · 17714-117-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →